Cost-Benefit Analysis of the FDA: The Case of the Prescription Drug User Fee Acts

Tomas Philipson, Ernst R. Berndt, Adrian H. B. Gottschalk and Eric Sun

No 217, Working Papers from The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State

Date: 2007
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.econstor.eu/bitstream/10419/262619/1/wp217.pdf (application/pdf)

Related works:
Journal Article: Cost-benefit analysis of the FDA: The case of the prescription drug user fee acts (2008)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:zbw:cbscwp:217

Access Statistics for this paper

More papers in Working Papers from The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State Contact information at EDIRC.
Bibliographic data for series maintained by ZBW - Leibniz Information Centre for Economics ().